Related Experiment Video
Updated: Feb 7, 2026

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
Published on: November 23, 2019
Autophagy as a mechanism of Apo2L/TRAIL resistance
Arishya Sharma1, Alexandru Almasan1,2
1a Department of Cancer Biology , Lerner Research Institute , Cleveland , OH , USA.
Abstract:
Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is unique to selectively induce apoptosis in tumor cells while sparing normal cells. Thus there is tremendous interest in Apo2L/TRAIL therapy; however, drug resistance is a serious limitation. Autophagy is a cellular housekeeping process that controls protein and organelle turnover, and is almost consistently activated in response to apoptosis-inducing stimuli, including Apo2L/TRAIL. Unlike apoptosis, autophagy leads to cell death or survival depending on the context. Various molecular mechanisms by which autophagy regulates Apo2L/TRAIL-induced apoptosis have been identified. Further, whether autophagy is completed (intact autophagic flux) or not could determine the fate of cancer cells, either cell survival or death. Thus, targeting autophagy is an attractive strategy to overcome Apo2L/TRAIL resistance. We present the current view of how these regulatory mechanisms of this interplay between autophagy and apoptosis may dictate cancer cell response to Apo2L/TRAIL therapy.
Insights
Apo2L/TRAIL therapy shows promise for cancer but faces drug resistance. Targeting autophagy, a cellular process, may overcome this resistance by influencing cancer cell survival or death in response to Apo2L/TRAIL.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Apo2L/TRAIL selectively induces apoptosis in tumor cells, offering therapeutic potential.
- Drug resistance remains a significant challenge in Apo2L/TRAIL therapy.
- Autophagy is consistently activated by apoptosis-inducing stimuli like Apo2L/TRAIL.
Purpose of the Study:
- To review the interplay between autophagy and apoptosis in cancer cells treated with Apo2L/TRAIL.
- To explore how autophagy modulation can overcome Apo2L/TRAIL resistance.
- To understand the role of autophagic flux in determining cancer cell fate.
Main Methods:
- Literature review of studies investigating Apo2L/TRAIL therapy and autophagy.
- Analysis of molecular mechanisms linking autophagy and apoptosis.
- Examination of factors influencing autophagic flux in cancer cells.
Main Results:
- Autophagy's role in Apo2L/TRAIL response is context-dependent, potentially leading to cell survival or death.
- Intact autophagic flux may be crucial for mediating cell death in response to Apo2L/TRAIL.
- Dysregulated autophagy can contribute to resistance against Apo2L/TRAIL therapy.
Conclusions:
- Targeting autophagy presents a promising strategy to enhance Apo2L/TRAIL efficacy.
- Understanding the balance between autophagy and apoptosis is key to overcoming drug resistance.
- Further research into modulating autophagy could lead to improved cancer treatment outcomes.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Resistivity
Resistance
Equivalent Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Rolling Resistance
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...

